Roots Analysis is pleased to announce the publication of its recent study, titled, “Drug Repurposing Market, 2020-2030.” Repurposing of marketed / ...
R A
DNA damage can be referred to as any adverse alteration, which may occur in the form of base additions, base deletions or break in the sister DNA strands. ...
Recent advances in information technology and biomedical science have enabled the development of a number of versatile digital solutions that are capable of ...
Over the years, the pharmaceutical industry has witnessed several advancements in drug development. It has gradually shifted from a one-drug treats all model ...
Advances in biotechnology have enabled the development of versatile in vitro (static and dynamic), in vivo (micro-dialysis), and in situ (brain perfusion) ...
Manufacturing highly potent drug products is technically and financially demanding; as a result, drug manufacturers are becoming increasingly reliant on ...
Several approved therapeutic products, which are currently available as intravenous dosage forms, are being reformulated and evaluated for subcutaneous ...
The demand for biopharmaceutical excipients has grown considerably in the past few years; they play a critical role in biologics development by enhancing the ...
The recent surge in the demand of radiopharmaceuticals for diagnostic and therapeutic applications, coupled with the introduction of theranostics, has opened ...
With six marketed drugs, ADCs are presently recognized as a potent class of targeted anticancer therapies, with the potential to be used to treat a variety of ...
- « Previous Page
- 1
- 2
- 3
- 4
- …
- 39
- Next Page »